Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
about
CarbapenemsIndividualised antibiotic dosing for patients who are critically ill: challenges and potential solutions.DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic.Penetration of doripenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers.Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.Modeling approach to characterize intraocular doripenem pharmacokinetics after intravenous administration to rabbits, with tentative extrapolation to humansPopulation Pharmacokinetics of Doripenem in Critically Ill Patients with Sepsis in a Malaysian Intensive Care Unit.Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae.Pharmacodynamic variability beyond that explained by MICs.Applications of pharmacometrics in the clinical development and pharmacotherapy of anti-infectives.Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship.Carbapenem susceptibility breakpoints, clinical implications with the moving target.The use and risks of antibiotics in critically ill patients.Therapeutic drug monitoring of anti-infective agents in critically ill patients.[Therapeutic drug monitoring and individual dosing of antibiotics during sepsis : Modern or just "trendy"?]Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.Doripenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy.Pharmacokinetics of doripenem in infected patients treated within and outside the intensive care unit.Standard versus prolonged doripenem infusion for treatment of gram-negative infections.Elimination of Doripenem during Dialysis and Pharmacokinetic Evaluation of Posthemodialysis Dosing for Patients Undergoing Intermittent Renal Replacement Therapy.
P2860
Q28286055-66ED9AC2-6102-485A-9033-0E5D9338F811Q34274190-9536E0B3-9D4E-424B-AB6C-6A3EE1C27FBEQ34329290-42E36668-15EA-4227-B6FF-72C3FC41AE43Q35666586-689417DC-E776-4992-BD67-BF6455AB1CBAQ36083619-34E66683-CE92-4C67-9ADB-F5E3801E9AB4Q36086333-5FC2F3CA-402F-4D52-994C-09F1BDF70B61Q36438971-A3FE5C01-D641-4C80-83FC-5B95C27EDF39Q36439114-AE839246-64CF-42CA-8B81-5A5C112DBFCEQ36757639-177915E3-50B4-449E-BE16-0531551E6FDCQ37259653-154292EE-6C46-428A-82AB-825F6F33301FQ38073197-24AEDCD1-9E0D-4CF2-A0A2-B95C813B61B9Q38751264-E2269647-62FC-4A77-8975-6B4417E3166CQ38767901-9D5AF4EA-8909-4AF7-8555-522F1B55E4AAQ38790740-957B5570-3A31-4439-9F13-5D5A94417B7CQ40541397-5CE36870-E100-4DE4-97F0-F87674497F37Q40677430-4E5241D5-B55E-4539-A803-FB5BF2AEC8ADQ42257467-5E4A8AD6-CB90-4279-961B-431BB62332B6Q43516275-B65C962E-DF2F-47A5-B9CE-5B3E49ED9BBEQ46357807-BB601C7B-3989-43CD-AF34-FC113525428CQ52807819-6DD0A282-FAD6-4C75-BEF5-82F127EDF6C5
P2860
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
@en
type
label
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
@en
prefLabel
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
@en
P2093
P2860
P356
P1476
Pharmacokinetic-pharmacodynamic-model-guided doripenem dosing in critically ill patients.
@en
P2093
Koné Kaniga
Mahesh N Samtani
Partha Nandy
P2860
P304
P356
10.1128/AAC.01843-09
P407
P577
2010-04-12T00:00:00Z